DE2651176A1 - Mittel mit geregelter wirkstoffabgabe und verfahren zu dessen herstellung - Google Patents
Mittel mit geregelter wirkstoffabgabe und verfahren zu dessen herstellungInfo
- Publication number
- DE2651176A1 DE2651176A1 DE19762651176 DE2651176A DE2651176A1 DE 2651176 A1 DE2651176 A1 DE 2651176A1 DE 19762651176 DE19762651176 DE 19762651176 DE 2651176 A DE2651176 A DE 2651176A DE 2651176 A1 DE2651176 A1 DE 2651176A1
- Authority
- DE
- Germany
- Prior art keywords
- release
- active component
- substance
- inactive
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Fertilizers (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7512883A SE418247B (sv) | 1975-11-17 | 1975-11-17 | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
Publications (2)
Publication Number | Publication Date |
---|---|
DE2651176A1 true DE2651176A1 (de) | 1977-05-18 |
DE2651176C2 DE2651176C2 (US07968547-20110628-C00004.png) | 1987-06-11 |
Family
ID=20326096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19762651176 Granted DE2651176A1 (de) | 1975-11-17 | 1976-11-10 | Mittel mit geregelter wirkstoffabgabe und verfahren zu dessen herstellung |
Country Status (24)
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4261971A (en) | 1978-12-05 | 1981-04-14 | Aktiebolaget Hassle | Pharmaceutically preparation comprising a cardiac glycoside in combination with a polymer |
US4263273A (en) | 1978-12-22 | 1981-04-21 | Aktiebolaget Astra | Pharmaceutical preparation comprising a cardiac glycoside with a polymer coating |
DE3613382A1 (de) * | 1985-04-22 | 1986-11-27 | Alza Corp., Palo Alto, Calif. | Osmotische abgabevorrichtung |
DE3721721C1 (de) * | 1987-07-01 | 1988-06-09 | Hoechst Ag | Verfahren zur Umhuellung von Granulaten |
DE3918801A1 (de) * | 1989-06-06 | 1991-05-08 | Schmidt Walter | Praeparat zur geregelten wirkstoffabgabe und verfahren zu dessen herstellung |
Families Citing this family (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2470600A2 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee |
DE2950977A1 (de) * | 1978-12-22 | 1980-07-10 | Donald E Panoz | Neue galenische zubereitungsform fuer die orale verabreichung von medikamenten mit programmierter besetzung, sowie verfahren zu ihrer herstellung |
FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
JPS5911563B2 (ja) * | 1980-02-27 | 1984-03-16 | 日本原子力研究所 | 多層構造の徐放性複合体を製造する方法 |
DE3264867D1 (en) * | 1981-04-27 | 1985-08-29 | Haessle Ab | New pharmaceutical preparation |
JPS5858146A (ja) * | 1981-10-05 | 1983-04-06 | Tanabe Seiyaku Co Ltd | 速放性マイクロカプセル |
US4370313A (en) * | 1981-10-26 | 1983-01-25 | Eaton Laboratories, Inc. | Nitrofurantoin dosage form |
EP0094117A3 (en) * | 1982-05-06 | 1984-08-01 | The Procter & Gamble Company | Therapeutic granules |
EP0094123A3 (en) * | 1982-05-06 | 1984-07-25 | THE PROCTER & GAMBLE COMPANY | Therapeutic granules |
EP0094116A3 (en) * | 1982-05-06 | 1984-08-01 | The Procter & Gamble Company | Therapeutic granules |
US4508702A (en) * | 1982-06-14 | 1985-04-02 | Key Pharmaceuticals, Inc. | Sustained release aspirin |
WO1984000004A1 (en) * | 1982-06-14 | 1984-01-05 | Key Pharma | Sustained release aspirin |
US4415547A (en) * | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
US4443428A (en) * | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
DE3382392D1 (de) * | 1982-07-09 | 1991-10-02 | Key Pharma | Dosierungsart zur dauerhaften verabreichung von chinidin. |
US4634587A (en) * | 1982-07-09 | 1987-01-06 | Key Pharmaceuticals, Inc. | Sustained release quinidine dosage form |
CA1223172A (en) * | 1982-09-23 | 1987-06-23 | Sidney Melamed | Encapsulated solid microbiocidal article |
US5283060A (en) * | 1982-09-29 | 1994-02-01 | Shieh Tsuong R | Bacillus-containing pesticide granules |
IL70071A (en) * | 1982-11-01 | 1987-12-31 | Merrell Dow Pharma | Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient |
US4461759A (en) * | 1983-01-03 | 1984-07-24 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of veropamil |
JPS59155309A (ja) * | 1983-02-22 | 1984-09-04 | Teijin Ltd | 活性型ビタミンd↓3類組成物 |
DE3306250A1 (de) * | 1983-02-23 | 1984-08-23 | Basf Ag, 6700 Ludwigshafen | Sphaerische einkristalle fuer pharmazeutische zwecke |
DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
GB2141023B (en) * | 1983-06-06 | 1986-09-03 | Robins Co Inc A H | Delayed release formulations |
US4555399A (en) * | 1983-11-18 | 1985-11-26 | Key Pharmaceuticals, Inc. | Aspirin tablet |
US4708867A (en) * | 1983-12-19 | 1987-11-24 | Key Pharmaceuticals, Inc. | Minipellets |
SE457505B (sv) * | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
DE3403329A1 (de) * | 1984-02-01 | 1985-08-01 | Horst Dr. 4019 Monheim Zerbe | Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe |
US4600645A (en) * | 1985-01-31 | 1986-07-15 | Warner-Lambert Company | Process for treating dosage forms |
SE458576B (sv) * | 1985-06-20 | 1989-04-17 | Lejus Medical Ab | Foerfarande foer framstaellning av en guar-gum produkt |
SE450087B (sv) * | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
SE455836B (sv) * | 1985-10-11 | 1988-08-15 | Haessle Ab | Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning |
US4898733A (en) * | 1985-11-04 | 1990-02-06 | International Minerals & Chemical Corp. | Layered, compression molded device for the sustained release of a beneficial agent |
US4826688A (en) * | 1985-11-13 | 1989-05-02 | 501 Elan Corporation PLC. | Controlled absorption pharmaceutical formulation |
US5100592A (en) * | 1986-03-12 | 1992-03-31 | Washington University Technology Associated, Inc. | Method and apparatus for granulation and granulated product |
US5019302A (en) * | 1986-03-12 | 1991-05-28 | Washington University Technology Associates, Inc. | Method for granulation |
US4861598A (en) * | 1986-07-18 | 1989-08-29 | Euroceltique, S.A. | Controlled release bases for pharmaceuticals |
US5624683A (en) * | 1986-08-06 | 1997-04-29 | Eisai Co., Ltd. | Sustained-release multi-granule tablet |
IT1200217B (it) * | 1986-09-30 | 1989-01-05 | Valducci Roberto | Membrana per uso farmaceutico ed industriale |
US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
KR910002669B1 (ko) * | 1986-12-25 | 1991-05-03 | 데이산세이야꾸 가부시끼가이샤 | 서방성 과립 및 그를 함유하는 지속성 복합과립 |
US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
GB8702411D0 (en) * | 1987-02-03 | 1987-03-11 | Zyma Sa | Swellable pellets |
HU197519B (en) * | 1987-06-22 | 1989-04-28 | Biogal Gyogyszergyar | Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade |
DE3720757A1 (de) * | 1987-06-24 | 1989-01-05 | Bayer Ag | Dhp-manteltablette |
US5219575A (en) * | 1987-06-26 | 1993-06-15 | Duphar International Research B.V. | Compositions with controlled zero-order delivery rate and method of preparing these compositions |
EP0297650A1 (en) * | 1987-06-26 | 1989-01-04 | Duphar International Research B.V | Compositions with controlled zero-order delivery rate and method of preparing these compositions |
IT1231410B (it) * | 1987-09-22 | 1991-12-04 | Cooperativa Farmaceutica | Composizione farmaceutica antiinfiammatoria ad effetto prolungato per uso topico |
SE8703881D0 (sv) * | 1987-10-08 | 1987-10-08 | Haessle Ab | New pharmaceutical preparation |
US4971805A (en) * | 1987-12-23 | 1990-11-20 | Teysan Pharmaceuticals Co., Ltd. | Slow-releasing granules and long acting mixed granules comprising the same |
US4925675A (en) * | 1988-08-19 | 1990-05-15 | Himedics, Inc. | Erythromycin microencapsulated granules |
US4925674A (en) * | 1988-08-25 | 1990-05-15 | Himedics, Inc. | Amoxicillin microencapsulated granules |
US4971796A (en) * | 1988-10-05 | 1990-11-20 | Sjogren Robert D | Slow release pest control granule composition |
DE3838094A1 (de) * | 1988-11-10 | 1990-05-17 | Nordmark Arzneimittel Gmbh | Feste pharmazeutische retardform |
EP0376331A3 (en) * | 1988-12-29 | 1991-03-13 | Asahi Kogaku Kogyo Kabushiki Kaisha | Slow release drug delivery granules and process for production thereof |
US5032406A (en) * | 1989-02-21 | 1991-07-16 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
US5084278A (en) * | 1989-06-02 | 1992-01-28 | Nortec Development Associates, Inc. | Taste-masked pharmaceutical compositions |
JP2813809B2 (ja) * | 1989-06-19 | 1998-10-22 | 武田薬品工業株式会社 | 有核顆粒製剤およびその製造法 |
US4966770A (en) * | 1989-07-26 | 1990-10-30 | Himedics, Inc. | Prednisone microencapsulated granules |
US6638963B1 (en) | 1990-12-04 | 2003-10-28 | Oregon Health And Science University | Methods for treating circadian rhythm disorders |
US5707652A (en) * | 1990-12-04 | 1998-01-13 | State Of Oregon | Methods of treating circadian rhythm phase disorders |
US5153002A (en) * | 1991-03-04 | 1992-10-06 | University Of Montreal | Biocompatible gradient controlled release implant |
FI93924C (fi) * | 1991-09-17 | 1995-06-26 | Martti Lauri Antero Marvola | Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi |
GB2267219B (en) * | 1992-05-28 | 1996-04-03 | Elan Corp Plc | Differential release tablet with multiple active agents |
ES2138070T3 (es) * | 1992-12-23 | 2000-01-01 | Saitec Srl | Proceso para la preparacion de formas farmaceuticas de liberacion controlada y las formas obtenidas de esta manera. |
IT1274879B (it) * | 1994-08-03 | 1997-07-25 | Saitec Srl | Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo. |
DE4446468A1 (de) * | 1994-12-23 | 1996-06-27 | Basf Ag | Verfahren zur Herstellung von umhüllten Tabletten |
US5762963A (en) * | 1995-06-07 | 1998-06-09 | Emory University | Method and compositions for controlling oral and pharyngeal pain using capsaicinoids |
US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
GB9703673D0 (en) * | 1997-02-21 | 1997-04-09 | Bradford Particle Design Ltd | Method and apparatus for the formation of particles |
EP1949890A3 (en) | 1999-06-04 | 2011-05-18 | ALZA Corporation | Implantable gel compositions and method of manufacture |
EP1183010A2 (en) * | 1999-06-04 | 2002-03-06 | ALZA Corporation | Implantable gel compositions and method of manufacture |
DK1276470T3 (da) | 2000-04-20 | 2007-06-18 | Novartis Ag | Smagskaskerende overtrækssammensætning |
KR100402053B1 (ko) * | 2000-09-28 | 2003-10-17 | 한국화학연구원 | 항생제의 서방성 임플란트 제제 |
GB0027357D0 (en) * | 2000-11-09 | 2000-12-27 | Bradford Particle Design Plc | Particle formation methods and their products |
JP4551089B2 (ja) * | 2001-10-29 | 2010-09-22 | マサチューセッツ インスティテュート オブ テクノロジー | 三次元印刷により製造されたゼロ次放出プロフィール投薬形態のような徐放投薬形態を製造するためのシステム |
US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
GB0216562D0 (en) | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
GB0228421D0 (en) * | 2002-12-05 | 2003-01-08 | Exosect Ltd | Lipid carriers |
DE10260919A1 (de) * | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug |
GB0310636D0 (en) * | 2003-05-08 | 2003-06-11 | Nektar Therapeutics Uk Ltd | Particulate materials |
AU2004237131B2 (en) | 2003-05-08 | 2009-09-10 | Nektar Therapeutics | Particulate materials |
WO2005096825A1 (en) * | 2004-03-31 | 2005-10-20 | Eid Parry (India) Limited | Improved granular formulation of neem seed extract and its process thereof |
US20050244465A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Drug delivery systems and methods for treatment of an eye |
EP1830814B1 (en) * | 2005-01-06 | 2009-07-01 | Cima Labs Inc. | Taste masking system for non-plasticizing drugs |
CA2767773C (en) | 2011-02-11 | 2015-11-24 | Grain Processing Corporation | Composition comprising a salt and a crystallization interrupter |
CA2936741C (en) | 2014-10-31 | 2018-11-06 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2128527A1 (de) * | 1970-06-08 | 1971-12-16 | Pharmacia As | Feste Arzneipraparate zur oralen Anwendung mit Langzeitwirkung und Ver fahren zu ihrer Herstellung |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2928770A (en) * | 1958-11-28 | 1960-03-15 | Frank M Bardani | Sustained action pill |
BE623704A (US07968547-20110628-C00004.png) * | 1961-10-20 | |||
US3383283A (en) * | 1964-01-24 | 1968-05-14 | Merck & Co Inc | Medicinal pellets coated with overlapping porous fatty acid leaflet layers |
FR1545612A (fr) * | 1967-06-15 | 1968-11-15 | Dausse Lab | Procédé de fabrication de comprimés |
DE1617351A1 (US07968547-20110628-C00004.png) * | 1967-06-28 | 1972-01-05 | ||
BE791632A (fr) * | 1971-11-20 | 1973-05-21 | Schering Ag | Supports a base de caoutchouc siliconique pour agents medicamenteux |
BE792502A (fr) * | 1971-12-09 | 1973-06-08 | Upjohn Co | Nouvelles formes pharmaceutiques et leur procede de preparation |
-
1975
- 1975-11-17 SE SE7512883A patent/SE418247B/xx not_active IP Right Cessation
-
1976
- 1976-11-08 ZA ZA766669A patent/ZA766669B/xx unknown
- 1976-11-09 NO NO763807A patent/NO144763C/no unknown
- 1976-11-10 DE DE19762651176 patent/DE2651176A1/de active Granted
- 1976-11-12 FI FI763257A patent/FI62462C/fi not_active IP Right Cessation
- 1976-11-15 DD DD7600195783A patent/DD128170A5/xx unknown
- 1976-11-15 AU AU19617/76A patent/AU508266B2/en not_active Expired
- 1976-11-15 DK DK513476A patent/DK146213C/da not_active IP Right Cessation
- 1976-11-15 NZ NZ182621A patent/NZ182621A/xx unknown
- 1976-11-16 GB GB47730/76A patent/GB1560841A/en not_active Expired
- 1976-11-16 NL NLAANVRAGE7612728,A patent/NL187259C/xx not_active IP Right Cessation
- 1976-11-16 CS CS767375A patent/CS207374B2/cs unknown
- 1976-11-16 CA CA265,748A patent/CA1075031A/en not_active Expired
- 1976-11-16 AT AT850576A patent/AT354636B/de not_active IP Right Cessation
- 1976-11-16 IE IE2516/76A patent/IE44353B1/en not_active IP Right Cessation
- 1976-11-16 FR FR7634515A patent/FR2331375A1/fr active Granted
- 1976-11-17 JP JP51137414A patent/JPS5919526B2/ja not_active Expired
- 1976-11-17 HU HU76HE724A patent/HU173461B/hu unknown
- 1976-11-17 LU LU76215A patent/LU76215A1/xx unknown
- 1976-11-17 SU SU762420506A patent/SU1326180A3/ru active
- 1976-11-17 BE BE172413A patent/BE848406A/xx not_active IP Right Cessation
-
1979
- 1979-02-21 US US06/013,124 patent/US4289795A/en not_active Expired - Lifetime
-
1980
- 1980-10-27 US US06/200,998 patent/US4341759A/en not_active Expired - Lifetime
-
1983
- 1983-05-05 HK HK146/83A patent/HK14683A/xx unknown
-
1984
- 1984-12-30 MY MY19/84A patent/MY8400019A/xx unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2128527A1 (de) * | 1970-06-08 | 1971-12-16 | Pharmacia As | Feste Arzneipraparate zur oralen Anwendung mit Langzeitwirkung und Ver fahren zu ihrer Herstellung |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4261971A (en) | 1978-12-05 | 1981-04-14 | Aktiebolaget Hassle | Pharmaceutically preparation comprising a cardiac glycoside in combination with a polymer |
US4263273A (en) | 1978-12-22 | 1981-04-21 | Aktiebolaget Astra | Pharmaceutical preparation comprising a cardiac glycoside with a polymer coating |
DE3613382A1 (de) * | 1985-04-22 | 1986-11-27 | Alza Corp., Palo Alto, Calif. | Osmotische abgabevorrichtung |
DE3721721C1 (de) * | 1987-07-01 | 1988-06-09 | Hoechst Ag | Verfahren zur Umhuellung von Granulaten |
US4935246A (en) * | 1987-07-01 | 1990-06-19 | Hoechst Aktiengesellschaft | Process for the coating of granules |
DE3918801A1 (de) * | 1989-06-06 | 1991-05-08 | Schmidt Walter | Praeparat zur geregelten wirkstoffabgabe und verfahren zu dessen herstellung |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2651176C2 (US07968547-20110628-C00004.png) | ||
DE3587274T2 (de) | Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend. | |
DE69002604T2 (de) | Pharmazeutische Zubereitung mit verzögerter Freisetzung und seine Herstellung. | |
DE3586600T2 (de) | Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend. | |
DE2336218C3 (de) | Orale Arzneiform | |
DE69111832T2 (de) | Naproxen-Formulierung zur kontrollierten Absorption zur einmal täglichen Anwendung. | |
EP0519870B1 (de) | Neue orale Diclofenaczubereitung | |
AT396329B (de) | Pharmazeutische granulate und verfahren zu ihrer herstellung | |
DE3751851T2 (de) | Verwendung von spezifischem Kernmaterial und Schichten zur Herstellung pharmazeutischer Formulierungen, die stabil gegen die Verfärbung säurelabiler Verbindungen sind | |
DE69331906T2 (de) | Granulierte pharmazeutische zusammensetzung | |
DE69131880T2 (de) | Zusammenfassungen und ihren Verwendung in der Behandlung von neurologischen Krankheiten | |
DE60103186T2 (de) | Stossweise freisetzende Arzneiabgabesysteme | |
DE69529050T2 (de) | Orale dosierungsformen mit pulverschicht | |
DE69021214T2 (de) | Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten. | |
DE19940944A1 (de) | Retardierte, orale, pharmazeutische Darreichungsformen | |
DE602005006409T2 (de) | Ein amin-arzneimittel enthaltende granulatzubereitung mit langsamer freisetzung auf basis von teilchen mit einer überzugsschicht und entsprechendes herstellungsverfahren | |
EP0068191A2 (de) | Orale Dipyridamolformen | |
DE19961897A1 (de) | Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen | |
DE3915150A1 (de) | Lang-wirkende diclofenac-natrium-praeparation | |
DE3838094A1 (de) | Feste pharmazeutische retardform | |
DE2741755C2 (de) | Überzugsmassen auf Polymerbasis für biologisch aktive Präparate, Verfahren zu ihrer Herstellung sowie mit diesen Überzugsmassen überzogene biologisch aktive Präparate und Verfahren zur Herstellung derselben | |
CH641358A5 (de) | Pharmazeutisches praeparat, enthaltend ein herzglykosid in kombination mit einem polymeren und verfahren zur herstellung desselben. | |
EP0185331B1 (de) | Theophyllin-Retardzubereitung | |
DE68907177T2 (de) | Dosierungsform. | |
DE60308828T2 (de) | Orale pharmazeutische Zusammensetzung mit verzögerter Freisetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |